List of current and past lab members
Mikko Myllymäki

Mikko Myllymäki, MD, PhD, is a Principal Investigator at the Faculty of Medicine and an affiliated Principal Investigator in the Translational Immunology Research Program (TRIMM), Research Programs Unit, University of Helsinki. He currently works as an Academy of Finland Clinical Research fellow. He is also specialising in clinical hematology at HUS Helsinki University Hospital/University of Helsinki. After graduating from University of Oulu, Finland, in 2016, he did a postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School, where he studied how telomere length and germline predisposition affect stem cell transplantation outcomes in myelodysplastic syndrome.

Miro Nylén

Miro Nylén, B.Med, is an MD/PhD student at the University Helsinki and an undergraduate bioinformatics student at Aalto University. His research is focused on investigating the clinical impact of clonal hematopoiesis on inherited and acquired disease conditions.

Emil Hiitola

Emil Hiitola, B.Sc., is a bioinformatics student at Aalto University and is currently doing his Master's thesis. His work focuses on the role of clonal hematopoiesis in inflammatory diseases.

Konstantin Matjusinski

Konstantin Matjusinski, B.Sc., is a Master's student in the Translational Medicine Program at University of Helsinki. Before joining the team, he studied the role of transcription factor Prox1 in radiation resistance and investigated the role of beta integrins and sharpin signalling pathways in maintaining vascular homeostasis. Konstantin is interested in studying how somatic genetic alterations, chronic disease conditions, and medications affect monocyte function in inflammatory diseases.

Rafeul Hasan

Rafeul Hasan, B.Sc., is currently working on his Master's thesis project in the research group. He is a Master's student at the Genetics and Molecular Biosciences Program at the University of Helsinki. The goal of his thesis is to evaluate whether germline genetic factors predisposing to clonal hematopoiesis are associated with inflammatory diseases.


Daehong Kim, Ph.D, originally from Seoul, Korea. During his PhD studies in the lab, Daehong explored the functional consequences of somatic mutations in hematologic malignancies and related autoimmune diseases. Currently a Postdoctoral Scientist at the Institute of Experimental Immunology, University of Zurich.

Milla Alakuijala, M.Sc, finalized her Master's degree at Aalto University (2022) when she worked on detecting clonal hematopoiesis using novel variant calling methods while combining her interests in medicine, bioinformatics, and computer science.  Currently an MD student at the University of Helsinki.

Juuso Korhonen, B.Sc, performed genetic analyses in the large population-level FINRISK study while working in the lab as a Master's student in Computer science at Aalto University. Currently works with image analyses and 3D modeling at Nokia Corporation.